复杂血管腔内主动脉修复术中计划性腹腔动脉栓塞后的胃肠道并发症及内脏循环变化
单中心12年70例复杂EVAR中计划性腹腔动脉栓塞患者,30天肠系膜并发症11.4%,31-90天额外上消化道出血2.9%,SMA支架相关肠系膜缺血5.7%;发生90天肠系膜并发症者2年生存率显著更低(42.5% vs 75.0%,P=0.002)。术后首次CT上SMA连接处侧支直径增加对90天肠系膜并发症有保护作用(OR 0.93,95%CI 0.87-0.96,P=0.046)。
要点
- 复杂EVAR中计划性CAE后90天内肠系膜并发症发生率约14%。
- 发生90天肠系膜并发症者2年总体生存率显著低于无并发症者。
- 术后早期SMA连接处侧支直径增加与90天肠系膜并发症风险降低相关。
核心结论
- 复杂EVAR中CAE是特定患者增加密封区的有用辅助手段,但术后90天内肠系膜并发症发生率为14%,发生肠系膜并发症者长期全因死亡率更高。
- CAE应作为血管外科医生在无法保留腹腔动脉的紧急情况下的工具箱技术之一。
- 作者认为仔细选择CAE候选者及术后早期监测侧支通路可能有助于预防和早期识别长期内脏并发症。
研究设计与样本
- 单中心12年期间(2011年至2023年)所有接受复杂血管腔内主动脉手术(EVAR和TEVAR)并计划性CAE的患者共70例。
- 回顾术前和术后临床、影像学及实验室资料,以识别CAE相关肠系膜并发症并评估长期生存和侧支解剖的影像学变化。
- 采用多因素logistic回归分析侧支血管直径变化与肠系膜并发症之间的关联。
主要发现
- 非SMA支架所致肠系膜并发症:30天肠系膜并发症11.4%,包括上消化道出血或溃疡穿孔(n=3)、胆囊炎(n=2)、胰腺炎(n=2)、缺血性肝炎(n=1)。
- CAE后31至90天,额外2例(2.9%)发生上消化道出血。
- SMA支架相关90天肠系膜并发症:额外4例(5.7%)发生SMA支架并发症导致肠系膜缺血。
- Kaplan-Meier分析显示,发生任何90天肠系膜并发症的患者2年总体生存率显著更低(42.5% vs 75.0%;P=0.002)。
- 术前影像显示20%患者存在SMA解剖变异,其中68.6%以胃十二指肠动脉作为优势SMA-腹腔侧支通路;术后无肠系膜并发症者在1、3-6、12和24个月时SMA和腹腔连接处侧支直径增加更大,1个月时与有并发症者相比直径差异有统计学意义(腹腔处中位数16.2% vs -2.1%,P=0.006;SMA处20.8% vs 7.7%,P=0.021)。
临床怎么用
- CAE应作为血管外科医生在无法保留腹腔动脉的紧急情况下的工具箱技术之一。
- 作者认为仔细选择CAE候选者及术后早期监测侧支通路可能有助于预防和早期识别长期内脏并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intentional celiac artery embolization (CAE) is an oft-used strategy to extend proximal or distal seal during complex endovascular aortic repair. Prior reports document a wide range of gastointestinal-related complications. However, associated changes in collateral circulation are poorly defined. We sought to report the long-term outcomes and adaptive changes in collateral visceral circulation following CAE during complex endovascular aortic repair. METHODS: All patients undergoing complex endovascular aortic procedures (endovascular aortic repair [EVAR] and thoracic EVAR) with CAE at a single institution over a 12-year period were included. Pre- and postoperative clinical, radiologic, and laboratory data were reviewed to identify mesenteric complications related to CAE and to assess long-term survival and radiologic changes in collateral anatomy. Multivariable logistic regression was used to determine the association between collateral vessel diameter change and mesenteric complications. RESULTS: From 2011 to 2023, 70 patients underwent planned CAE during complex EVAR. With regards to mesenteric complications not attributable to the superior mesenteric artery (SMA) stent, 11.4% had 30-day mesenteric complications, including upper gastrointestinal bleed or perforated ulcer (n = 3), cholecystitis (n = 2), pancreatitis (n = 2), and ischemic hepatitis (n = 1). During 31 to 90 days after CAE, two additional patients (2.9%) had upper gastrointestinal bleed. With regards to 90-day mesenteric complications related to the SMA stent, four additional patients (5.7%) had SMA stent complications leading to mesenteric ischemia. On Kaplan-Meier analysis, patients with any 90-day mesenteric complication had significantly lower overall 2-year survival (42.5% vs 75.0%; P = .002). On preoperative imaging, 20% of patients had variant SMA anatomy with the gastroduodenal artery as the dominant SMA-celiac collateral pathway in 68.6%. Postoperatively, patients without mesenteric complications had a greater increase in the collateral diameter at both SMA and celiac junctions at 1, 3 to 6, 12, and 24 months, with a statistically significant difference in diameter at 1 month compared with patients with complications (median: 16.2% vs -2.1% at celiac; P = .006 and 20.8% vs 7.7% at SMA; P = .021). On adjusted multivariate regression, increase in collateral diameter at the SMA junction on first postoperative computed tomography was significantly protective of 90-day mesenteric complications (odds ratio, 0.93; 95% confidence interval, 0.87-0.96; P = .046). CONCLUSIONS: CAE during complex EVAR is a useful adjunct to increase seal zone in select patients; however, mesenteric complications occur in 14% of the patients over a 90-day postoperative period, and patients with mesenteric complications have a higher long-term all-cause mortality. CAE should be a technique within the toolbox of vascular surgeons for urgent circumstances that do not allow for celiac preservation. Careful selection of candidates for CAE and early postoperative surveillance of collateral pathways may help with prevention and early identification of long-term visceral complications.
引用
- Fereydooni A, Franca CT, Sorondo SM, et al. Gastrointestinal complications and visceral circulation changes after intentional celiac artery embolization during complex endovascular aortic repair. J Vasc Surg. 2024. PMID: 39608413. doi:10.1016/j.jvs.2024.11.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。